Zobrazeno 1 - 10
of 507
pro vyhledávání: '"Callea V"'
Autor:
Palumbo, A. *, Gay, F., Bringhen, S., Falcone, A., Pescosta, N., Callea, V., Caravita, T., Morabito, F., Magarotto, V., Ruggeri, M., Avonto, I., Musto, P., Cascavilla, N., Bruno, B., Boccadoro, M.
Publikováno v:
In Annals of Oncology June 2008 19(6):1160-1165
Autor:
Tarella C, Ladetto M, Benedetti F, Vitolo U, Pulsoni A, Patti C, Callea V, Rambaldi A, Piccin A, Devizzi L, Musso M, Iannitto E, Spedini P, Liberati AM, Gallamini A, Rodeghiero F, Gini G, De Crescenzo A, Di Raimondo F, Levis A, Chisesi T, Petrone T, Scalabrini DR, Rossi G, Carella AM, Parvis G, Majolino I, Passera R, Ruella M, Pileri A, Gianni AM, Corradini P., CICERI , FABIO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::8fcb9c65a3863b345df68a163d555e21
Autor:
Foà, R, Del Giudice, I, Cuneo, Antonio, Del Poeta, G, Ciolli, S, Di Raimondo, F, Lauria, F, Cencini, E, Rigolin, Gian Matteo, Cortelezzi, A, Nobile, F, Callea, V, Brugiatelli, M, Massaia, M, Molica, S, Trentin, L, Rizzi, R, Specchia, G, Di Serio, F, Orsucci, L, Ambrosetti, A, Montillo, M, Luigi Zinzani, P, Ferrara, F, Morabito, F, Angela Mura, M, Soriani, S, Peragine, N, Tavolaro, S, Bonina, S, Marinelli, M, Stefania De Propris, M, Della Starza, I, Piciocchi, A, Alietti, A, Runggaldier, Ej, Gamba, E, Romana Mauro, F, Chiaretti, S, Guarini, A.
In a phase II trial, we evaluated chlorambucil and rituximab (CLB-R) as first-line induction treatment with or without R as maintenance for elderly chronic lymphocytic leukemia (CLL) patients. Treatment consisted of eight 28-day cycles of CLB (8 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::682736e1e786dec3c7b31014734ed3ff
http://hdl.handle.net/11585/506405
http://hdl.handle.net/11585/506405
Autor:
Ladetto, M, DE MARCO, F, Benedetti, F, Vitolo, U, Patti, C, Rambaldi, A, Pulsoni, Alessandro, Musso, M, Liberati, Am, Olivieri, A, Gallamini, A, Pogliani, E, Scalabrini, Dr, Callea, V, DI RAIMONDO, F, Pavone, V, Tucci, A, Cortelazzo, S, Levis, A, Boccadoro, M, Majolino, I, Pileri, A, Gianni, Am, Passera, R, Corradini, P, Tarella, C, GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO GITMO, INTERGRUPPO ITALIANO LINFOMI IIL, Foa, Roberto
In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were compared with rituximab-supplemented high-dose sequential chemotherapy with autograftin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc196522b7aac98eba3358e16a146b4
http://hdl.handle.net/11573/116879
http://hdl.handle.net/11573/116879
Autor:
Arcaini, L, Lazzarino, M, Colombo, N, Burcheri, S, Boveri, E, Paulli, M, Morra, E, Gambacorta, M, Cortelazzo, S, Tucci, A, Ungari, M, Ambrosetti, A, Menestrina, F, Orsucci, L, Novero, D, Pulsoni, A, Frezzato, M, Gaidano, G, Vallisa, D, Minardi, V, Tripodo, C, Callea, V, Baldini, L, Merli, F, Federico, Massimo, Franco, V, Iannitto, E, INTEGRUPPO ITALIANO LINFOMI
The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5-year cause-specific survival (CSS) rate was 76%. In univariate analysis, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00bac53573dda9154889da21834af84e
http://www.bloodjournal.org/cgi/reprint/107/12/4643
http://www.bloodjournal.org/cgi/reprint/107/12/4643
Autor:
Palumbo A, Bringhen S, Caravita T, Merla E, Capparella V, Callea V, Cangialosi C, Grasso M, Rossini F, Galli M, Catalano L, Petrucci MT, De Stefano V, Ceccarelli M, Ambrosini MT, Avonto I, Falco P, Ciccone G, Liberati AM, Musto P, Boccadoro M, Italian Multiple Myeloma Network, GIMEMA, ZAMAGNI, ELENA
Summary Background Since 1960, oral melphalan and prednisone (MP) has been regarded as the standard of care in elderly multiple myeloma patients. This multicentre randomised trial compared oral MP plus thalidomide (MPT) with MP alone in patients aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c7de4aee2ad82f57ed6c5743548313
https://hdl.handle.net/11380/716243
https://hdl.handle.net/11380/716243
Autor:
Iannitto, E., Cantis, Stefano, Minardi, V., Callea, V., Calvaruso, G., Mule, A., Stelitano, C., Claudio Tripodo, Quintini, G., Ambrosetti, A., Pizzolo, G., Franco, V., Abbadessa, V.
Publikováno v:
Università degli Studi di Palermo-IRIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9dedaa0ff60efe4493399b72cfaa560f
http://hdl.handle.net/10447/1716
http://hdl.handle.net/10447/1716
Autor:
IANNITTO E, AMBROSETTI A, CALLEA V, STELITANO C, TRIPODO, Claudio, CALVARUSO G, MITRA ME, PATTI K, PIZZOLO G., FLORENA, Ada Maria, MINARDI, Viviana Maria, DE CANTIS, Stefano, ABBADESSA, Vincenzo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::9dca8a669b5187f2fcb7786be34dd1cb
http://hdl.handle.net/10447/5172
http://hdl.handle.net/10447/5172
Autor:
Cortelezzi, A, Gritti, G, Laurenti, L, Cuneo, Antonio, Ciolli, S, Di Renzo, N, Musto, P, Mauro, Fr, Cascavilla, N, Falchi, L, Zallio, F, Callea, V, Maura, F, Martinelli, S, Piciocchi, A, Reda, G, Foà, R, on behalf of the GIMEMA Chronic Lymphoproliferative Disorders Working Party
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3709::cf1a454571f8ec7ebfdf98c1826f599f
http://hdl.handle.net/11392/1588665
http://hdl.handle.net/11392/1588665
Autor:
Cortelezzi, A., Gritti, G., Laurenti, L., Cuneo, Antonio, Ciolli, S., Di Renzo, N., Musto, P., Mauro, F., D’Arena, G., Falchi, L., Zallio, F., Callea, V., Maura, F., Martinelli, S., Piciocchi, A., Reda, G., Foà, R.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2fbed794a7436c1fed9f60db9ddd117c
http://hdl.handle.net/11573/473487
http://hdl.handle.net/11573/473487